Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,404 | -28,316 | -96,749 | -97,027 | -56,956 |
| Depreciation Amortization | 9,402 | 4,901 | 14,156 | 11,538 | 7,173 |
| Accounts receivable | -2,879 | -33 | -13,091 | 9,771 | 4,325 |
| Accounts payable and accrued liabilities | 796 | -6,474 | 177 | -2,172 | 2,330 |
| Other Working Capital | -4,688 | -7,555 | -12,297 | 9,798 | 10,557 |
| Other Operating Activity | -15,408 | 865 | 3,242 | -15,388 | -20,483 |
| Operating Cash Flow | $-60,181 | $-36,612 | $-104,562 | $-83,480 | $-53,054 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 15,000 | 26,698 | 23,698 |
| PPE Investments | -1,541 | -626 | -18,543 | -18,254 | -13,641 |
| Net Acquisitions | -744 | -296 | 10,979 | N/A | N/A |
| Purchase Of Investment | -252 | -60 | -143 | -81 | -93 |
| Purchase Sale Intangibles | N/A | N/A | -13 | -880 | -23 |
| Other Investing Activity | 0 | 0 | -14 | -880 | -23 |
| Investing Cash Flow | $-2,537 | $-982 | $7,279 | $7,483 | $9,941 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,969 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -30 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 56,239 | 58,555 | 58,969 |
| Other Financing Activity | 4,338 | 7,707 | -8,714 | -9,607 | -6,339 |
| Financing Cash Flow | $10,307 | $7,677 | $47,525 | $48,948 | $52,630 |
| Exchange Rate Effect | -3,785 | -852 | -5,754 | -3,389 | -2,439 |
| Beginning Cash Position | 185,636 | 185,636 | 241,148 | 241,148 | 241,148 |
| End Cash Position | 129,440 | 154,868 | 185,636 | 210,709 | 248,226 |
| Net Cash Flow | $-56,196 | $-30,768 | $-55,512 | $-30,439 | $7,078 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,181 | -36,612 | -104,562 | -83,480 | -53,054 |
| Capital Expenditure | -1,541 | -626 | -18,543 | -18,254 | -13,641 |
| Free Cash Flow | -61,722 | -37,238 | -123,105 | -101,734 | -66,695 |